Induction of labour with cervical ripening balloon associated with oral misoprostol: an observational study comparing sequential and concurrent administration

Author:

Mancarella Matteo1ORCID,Attianese Daniela,Moggio Giulia,Novara Lorenzo,Pecchio Silvia,Ambrogio Alessia,Covino Roberta,De Chiesa Francesca,Fuso Luca,Sgro Luca Giuseppe,Ferrero Annamaria,Bounous Valentina Elisabetta

Affiliation:

1. Azienda Ospedaliera Ordine Mauriziano di Torino

Abstract

Abstract

Purpose. The association of cervical ripening balloons (CRB) and misoprostol for induction of labour (IoL) is frequently used, although there is poor evidence about the optimal timing and protocol for their combination. The aim of this study was to compare a concurrent and a sequential scheme for administration of oral misoprostol in association with CRB, in terms of mode and timing of delivery and rate of adverse events. Methods. This was an observational study comparing two consecutive cohorts of women with unfavourable cervix undergoing IoL by means of CRB combined with oral misoprostol, with either a sequential scheme (retrospective cohort, N = 36) or a concurrent administration (prospective cohort, N = 30). Primary outcome was the rate of vaginal delivery (VD); secondary outcomes included the interval of time to labour and delivery and the incidence of maternal or perinatal complications. Results. The concurrent administration of misoprostol combined with CRB resulted in a similar rate of VD compared to the sequential scheme (63.9% vs 76.7%, p = 0.29). Both time to active labour (32.7 +/- 10.9 vs 21.8 +/- 9.6hours, p = 0.001) and to vaginal delivery (34.0 +/- 12.6 vs 25.3 +/- 10.2 hours, p = 0.016) were shorter for concurrent misoprostol administration, resulting in a higher rate of VD within 24 hours (13.9 % vs 43.3%, p = 0.01). The rate of maternal and perinatal adverse outcomes did not differ significantly between the two groups. Conclusion. A concurrent use of CRB and oral misoprostol might be preferable due to similar results in terms of mode of delivery, achieved in a shorter time with no increase in complications; futher studies on larger populations will be needed to verify potential differences in CS rates and rare adverse events.

Publisher

Springer Science and Business Media LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3